Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 17 records per page: next > | last >>
pages: 1 2 3 4 5 ... 14 15 16 17 presentations: 1 to 50 of 843
SESSION OVERVIEW - HIV AND THE MICROBIOME: NEW THEMES
Ronald G. Collman
University of Pennsylvania, Philadelphia, PA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
CHANGES IN GUT MICROBIOTA PROFILE IN PWHIV WHO SWITCH FROM EFV/FTC/TDF TO BIC/FTC/TAF   (ABSTRACT 248)
Sandra Pinto-Cardoso
Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, Mexico
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
PROTEOMIC ANALYSIS OF TRANSLOCATING BACTERIAL TAXA REVEALS NOVEL THERAPEUTIC TARGET   (ABSTRACT 249)
Jacob K. Flynn
National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
THE EFFECTS OF CD4+ LYMPHOPENIA ON THE HUMAN SKIN MICROBIOME   (ABSTRACT 250)
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
COMMENSAL BACTERIA WITHIN THE FAMILY LACHNOSPIRACEAE ROBUSTLY INHIBIT HIV INFECTION   (ABSTRACT 251)
Danting Jiang
Duke University School of Medicine, Durham, NC, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
BACTERIAL DYSBIOSIS PERSISTS IN WOMEN LIVING WITH HIV-1 AFTER ART-TREATMENT   (ABSTRACT 252)
Katherine M. Bricker
National Institutes of Health, Bethesda, MD, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Ronald G. Collman
University of Pennsylvania, Philadelphia, PA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW-NEW INSIGHTS ON RECENT INFECTION
George W. Rutherford
University of California San Francisco, San Francisco, CA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
HOTSPOTS OF RECENT HIV INFECTIONS AMONG ADULT PEOPLE LIVING WITH HIV IN NIGERIA   (ABSTRACT 847)
Amobi A. Onovo
University of Geneva, SILVER SPRING, MD, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
PROGRAMMATIC IMPLICATIONS OF NATIONAL RECENT HIV INFECTION SURVEILLANCE IN CAMBODIA   (ABSTRACT 848)
Amitabh B. Suthar
Centers for Disease Control and Prevention, Atlanta, GA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
AN ANALYSIS OF HIV RECENT INFECTION SURVEILLANCE DATA AMONG YOUNG PEOPLE IN MALAWI   (ABSTRACT 849)
Reno Stephens
Centers for Disease Control and Prevention, Lilongwe, Malawi
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
HIV RECENT INFECTION IN SEXUAL AND GENDER MINORITIES IN BRAZIL AND PERU: ImPREP STUDY   (ABSTRACT 850)
Thiago S. Torres
Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
HIV TIME-SPACE ALERTS AMONG PWID AND MSM IN THE UNITED STATES: 2018-2021   (ABSTRACT 851)
Camden J. Hallmark
Centers for Disease Control and Prevention, Atlanta, GA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
George W. Rutherford
University of California San Francisco, San Francisco, CA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW-PREDICTORS OF TB TREATMENT OUTCOMES
Amita Gupta
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
TB OUTCOMES IN PEOPLE LIVING WITH HIV: AN INTEGRATIVE DATA ANALYSIS OF PHASE 3 TRIALS   (ABSTRACT 740)
Rob van Wijk
University of California San Francisco, San Francisco, CA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
PREDICTORS OF POOR OUTCOMES IN PATIENTS WITH TUBERCULOSIS SYMPTOMS AT HIV DIAGNOSIS   (ABSTRACT 742)
Nancy Dorvil
GHESKIO, Port-au-Prince, Haiti
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
TREATMENT OUTCOMES OF PERSONS WITH DSTB ON A MEDICATION MONITOR AND ADHERENCE SUPPORT   (ABSTRACT 745)
Catherine Orrell
Desmond Tutu Health Foundation, Cape Town, South Africa
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Amita Gupta
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW - STEATOHEPATITIS: SEX DIFFERENCES AND OTHER RISK FACTORS
Susanna Naggie
Duke University, Durham, NC, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
PREVALENCE AND FACTORS ASSOCIATED WITH NAFLD IN PEOPLE WITH HIV   (ABSTRACT 609)
Louise E. van Eekeren
Radboud University Medical Center, Nijmegen, Netherlands
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
LIVER STEATOSIS AND FIBROSIS IN WOMEN WITH HIV BY INTEGRASE INHIBITOR USE   (ABSTRACT 610)
Cecile D. Lahiri
Emory University, Atlanta, GA, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC-FATTY LIVER DISEASE   (ABSTRACT 611)
Dana Kablawi
McGill University Health Centre, Montreal, Canada
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
NAFLD AND ITS COMBINATION WITH NASH PREDICT DM DEVELOPMENT IN PEOPLE WITH HIV   (ABSTRACT 612)
Win Min Han
Thai Red Cross AIDS Research Center, Bangkok, Thailand
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Susanna Naggie
Duke University, Durham, NC, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW - UNDERSTANDING MORTALITY IN PEOPLE WITH HIV
Maureen Syowai
ICAP at Columbia University, Nairobi, Kenya
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
TRENDS IN MORTALITY IN PEOPLE LIVING WITH HIV IN AN INTERNATIONAL COHORT (RESPOND)   (ABSTRACT 870)
Erich Tusch
University of Copenhagen, Copenhagen, Denmark
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
PROPORTION OF DEATHS OCCURRING OUTSIDE OF HEALTH FACILITIES ATTRIBUTABLE TO HIV/AIDS   (ABSTRACT 872)
Newton L. Kalata
Centers for Disease Control and Prevention, Lilongwe, Malawi
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
MEASURING EXCESS MORTALITY ASSOCIATED WITH HIV: ESTIMATES FROM THE PHIA PROJECT   (ABSTRACT 873)
Shannon M. Farley
ICAP at Columbia University, New York, NY, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
ONE-YEAR MORTALITY OF PEOPLE WITH HIV AFTER INTENSIVE CARE UNIT ADMISSION   (ABSTRACT 874)
Caroline Sabin
University College London, London, United Kingdom
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
REGISTRY LINKAGE IMPROVES SURVIVAL ESTIMATION AMONG PEOPLE WITH HIV IN LATIN AMERICA   (ABSTRACT 875)
Peter F. Rebeiro
Vanderbilt University, Nashville, TN, United States
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Maureen Syowai
ICAP at Columbia University, Nairobi, Kenya
from CROI 2023 on February 20, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW-A VIRUS ON MY MIND: UNRAVELING LINKS BETWEEN HIV AND MENTAL HEALTH SYMPTOMS
Sean B. Rourke
St. Michael's Hospital, Toronto, Canada
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
EFFECT OF COMMON ANTIRETROVIRAL COMBINATIONS ON DEPRESSIVE SYMPTOMS IN WOMEN WITH HIV   (ABSTRACT 469)
Luis Parra-Rodriguez
Washington University in St Louis, St. Louis, MO, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
(NEURO)INFLAMMATORY BIOMARKERS MEDIATE THE ASSOCIATION BETWEEN HIV AND DEPRESSION   (ABSTRACT 476)
Jaime Vera
Brighton and Sussex Medical School, Brighton, United Kingdom
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
PSYCHIATRIC SYMPTOMS IN PLHIV: PREVALENCES, INTERACTIONS AND CONSEQUENCES   (ABSTRACT 472)
Elise M. G. Meeder
Radboud University Medical Center, Nijmegen, Netherlands
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
BIOPSYCHOSOCIAL PHENOTYPES IN PEOPLE WITH HIV IN THE CHARTER COHORT   (ABSTRACT 474)
Ronald J. Ellis
University of California San Diego, San Diego, CA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
SLEEP DISTURBANCES ARE ASSOCIATED WITH COGNITIVE FUNCTION IN WOMEN LIVING WITH HIV   (ABSTRACT 473)
Raha M. Dastgheyb
The Johns Hopkins University, Baltimore, MD, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Sean B. Rourke
St. Michael's Hospital, Toronto, Canada
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW-ADVANCES IN PrEP DELIVERY IN SUB-SAHARAN AFRICA
Andrew Mujugira
Makerere University, Auburn, WA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
A PILOT RCT ASSESSING UPTAKE OF PrEP AND CONTRACEPTION IN HAIR SALONS IN SOUTH AFRICA   (ABSTRACT 999)
Ingrid Bassett
Massachusetts General Hospital, Boston, MA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
PHARMACY-BASED PrEP DELIVERY IN KENYA: FINDINGS FROM A PILOT STUDY EXTENSION   (ABSTRACT 978)
Stephanie Roche
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
EFFECTS OF 6-MONTH PrEP DISPENSING WITH HIV SELF-TESTING ON SEXUAL BEHAVIORS IN KENYA   (ABSTRACT 977)
Ashley R. Bardon
University of Washington, Manchester, MO, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
INCREASED UPTAKE OF BIOMEDICAL HIV PREVENTION BY YOUTH THROUGH COMMUNITY-BASED SRH   (ABSTRACT 976)
Maryam Shahmanesh
Africa Health Research Institute, Durban, South Africa
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
RANDOMIZED TRIAL OF DYNAMIC CHOICE PREVENTION AT OUTPATIENT DEPARTMENT IN EAST AFRICA   (ABSTRACT 975)
Catherine Koss
University of California San Francisco, San Francisco, CA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Andrew Mujugira
Makerere University, Auburn, WA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
SESSION OVERVIEW-DYNAMICS OF PROVIRAL INTEGRATION
Lillian Cohn
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
DISTINCT INTEGRATION SITES OF INTACT HIV-1 PROVIRUSES IN POST-TREATMENT CONTROLLERS   (ABSTRACT 453)
Isabelle C. Roseto
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
CTL SELECTION ENRICHES FOR HIV INTEGRATION SITE FEATURES AND EXPANDED CLONES IN VIVO   (ABSTRACT 451)
Noemi L. Linden
Weill Cornell Medicine, New York, NY, United States
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
IMPACT OF HIV RESERVOIR IN THE LOSS OF NATURAL ELITE CONTROL OF HIV-1 INFECTION   (ABSTRACT 452)
Carmen Gasca-Capote
Virgen del Rocío University Hospital, Rota, Spain
from CROI 2023 on February 21, 2023 1:30 PM-2:30 PM
<< first | < prev page: of 17 records per page: next > | last >>
pages: 1 2 3 4 5 ... 14 15 16 17 presentations: 1 to 50 of 843